Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/2010
07/13/2010CA2423488C Thermogelling biodegradable aqueous polymer solution
07/13/2010CA2420350C Membrane penetrating peptides and uses thereof
07/13/2010CA2414239C Analgesic anti-inflammatory patch for topical application
07/13/2010CA2356533C Inhibitors of the bitter taste response
07/13/2010CA2349503C Particles coated with granulated crystalline ibuprofen
07/13/2010CA2345932C Peptide-based carrier devices for stellate cells
07/08/2010WO2010078538A2 Enhanced carriers for the delivery of microparticles to bodily tissues and fluids
07/08/2010WO2010078419A2 Herbal-based nasal solution and method of use thereof
07/08/2010WO2010078036A2 Biocompatible polysaccharide-based hydrogels
07/08/2010WO2010077867A2 Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
07/08/2010WO2010077853A2 Mono- and di-peg il-10 production; and uses
07/08/2010WO2010077671A2 Stable perfluorocarbon emulsion for use as an artificial oxygen carrier
07/08/2010WO2010077165A1 Phospholipid emulsion containing dihydroquercetin, and method of producing thereof
07/08/2010WO2010077156A1 Composition for prolonged release of heparin and use of the alginate-hydroxypropylcellulose gel for prolonged release of heparin
07/08/2010WO2010077061A2 Pharmaceutical formulations containing antiviral drugs
07/08/2010WO2010077045A2 Pharmaceutical composition of lyophilized formulation and preparation method of the same
07/08/2010WO2010076340A1 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
07/08/2010WO2010075801A1 Pharmaceutical formulations comprising voriconazole and processes for preparation thereof
07/08/2010WO2010075665A1 A formulation of silibinin with high efficiency and prolonged action and the preparation method thereof
07/08/2010WO2010075664A1 A highly efficient and long-acting slow-release formulation of poorly soluble drugs and preparation method thereof
07/08/2010WO2010075663A1 A formulation of silymarin with high efficiency and prolonged action and the preparation method thereof
07/08/2010WO2010049485A3 Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate
07/08/2010WO2010045431A3 Dry powder formulations, vaccines and methods
07/08/2010WO2010010531A9 Composition for controlling increase in blood glucose
07/08/2010WO2009114776A3 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
07/08/2010US20100174222 Method and apparatus for acne treatment using low intensity light therapy
07/08/2010US20100174001 Antioxidant for food
07/08/2010US20100173969 Therapeutic agent
07/08/2010US20100173904 Topical composition, topical composition precursor, and methods for manufacturing and using
07/08/2010US20100173870 Phosphonate Compounds
07/08/2010US20100173855 Dermatological Formulations
07/08/2010US20100173005 Microparticle formulations for sustained-release of bioactive compounds
07/08/2010US20100172986 Controlled release composition and preparation thereof
07/08/2010US20100172976 Methods and compositions for inhibiting the function of polynucleotide sequences
07/08/2010US20100172974 Melt-extruded orally administrable opioid formulations
07/08/2010US20100172970 Dosage forms made by melt extrusion with water soluble polymer to improve bioavailability; once daily oral dosage form; antivirals such as 4-[[4-amino-5-chloro-6-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile for treating non-nucleoside reverse transcriptase inhibitor resistant HIV
07/08/2010US20100172968 Chimeric cannulae proteins and methods for making and using them
07/08/2010US20100172967 Compound modified with glycerol derivative
07/08/2010US20100172956 Dissolving strip for oral mucosa as a systemic drug delivery route
07/08/2010US20100172930 Transfection complexes
07/08/2010US20100172849 Silicone elastomer gels
07/08/2010US20100172845 Compositions and methods for treating mycobacterial infections
07/08/2010US20100172832 Diagnosis and treatment of malignant neoplasms
07/08/2010US20100172829 Enhanced carriers for the delivery of microparticles to bodily tissues and fluids
07/08/2010DE102004012273B4 Stabile und geschmacksmaskierte pharmazeutische Dosierungsform unter Verwendung von porösen Apatit-Körnern Stable and taste masked pharmaceutical dosage form using porous apatite grains
07/08/2010CA2749757A1 Injectable botulinum toxin formulations
07/08/2010CA2748907A1 Enhanced carriers for the delivery of microparticles to bodily tissues and fluids
07/08/2010CA2748761A1 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
07/08/2010CA2748365A1 Pharmaceutical composition of lyophilized formulation and preparation method of the same
07/08/2010CA2746781A1 Biocompatible polysaccharide-based hydrogels
07/08/2010CA2745443A1 Mono- and di-peg il-10 production; and uses
07/07/2010EP2204398A1 Camptothecin polymer derivative and uses of the same
07/07/2010EP2204385A1 Pseudomonas exotoxin A mutants and uses thereof
07/07/2010EP2204229A1 Method of producing emulsion or dispersion and food, skin external preparation and drug containing emulsion or dispersion obtained by the production method
07/07/2010EP2204193A2 Novel spacer moiety for poly(ethylene glycol)-modified peptide-based compounds
07/07/2010EP2204186A1 Immunogenic complexes and methods relating thereto
07/07/2010EP2204185A1 Combined meningitis vaccine
07/07/2010EP2204182A1 Non-cytotoxic protein conjugates
07/07/2010EP2204174A1 Metronidazole solubilisation process with niacinamide and two glycols, and the resulting solution
07/07/2010EP2204169A1 Granular preparation containing biguanide compound
07/07/2010EP2204167A1 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
07/07/2010EP2203498A1 Oligofluorinated cross-linked polymers and uses thereof
07/07/2010EP2203181A2 An orally administerable solid pharmaceutical composition and a process thereof
07/07/2010EP2203179A1 Vancomycin and teicoplanin anhydrous formulations for topical use
07/07/2010EP1545595B1 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
07/07/2010EP1446126B1 Coated particulate cefuroxime axetil compositions
07/07/2010EP1079862B1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
07/07/2010CN101772513A Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
07/07/2010CN101772353A Oxidized avidin with high residency time in the treated tissues
07/07/2010CN101772352A Liquid composition for soft-capsule filling
07/07/2010CN101772345A A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol
07/07/2010CN101772341A Compositions for delivering a drug
07/07/2010CN101768279A Hydroxypropy rotaxane-phospholipid polymer, preparation method thereof and application thereof
07/07/2010CN101768276A Methoxy polyethylene glycol-polycaprolactone-polyethyleneimine triblock copolymer and application thereof
07/07/2010CN101766824A Mixed copolymer carrier system compound and preparation method thereof
07/07/2010CN101766823A Water-soluble natural bate-carotin preparation method
07/07/2010CN101766822A Piroxicam beta-cyclodextrin inclusion compounds and preparation method of tablets thereof
07/07/2010CN101766821A Application of polymer based on beta-cyclodextrin
07/07/2010CN101766820A Novel method for preparation of chitosan nano carrier and functionalization thereof
07/07/2010CN101766819A Heparin complex as well as preparation method and application thereof
07/07/2010CN101766818A Polysaccharide gold-magnetic composite particle medicine carrier and preparation method thereof
07/07/2010CN101766817A Medicine carrier and application thereof
07/07/2010CN101766816A Dipolar molecule-modified mesoporous silicon material, preparation and application thereof
07/07/2010CN101766813A Suppository for treating mammalian endometritis and preparation method thereof
07/07/2010CN101766812A Liquid drug combination containing exenatide or analogues thereof
07/07/2010CN101766811A Application of exenatide acetate or analogue thereof in preparing drug for treating or preventing diabetes complicated with cerebral infarction
07/07/2010CN101766807A Injection packaging preparation of thymosin pha1 microspheres
07/07/2010CN101766805A Stabilized antibacterial peptide preparation and preparation method thereof
07/07/2010CN101766722A Spray formula with slough-eliminating and granulation-promoting effects
07/07/2010CN101766697A Antifungal medicament for treating skin tinea and preparation method thereof
07/07/2010CN101766692A Channel-freeing harmonizing emulsion
07/07/2010CN101766657A Compound for activating immune cell and preparation method thereof
07/07/2010CN101766656A Combination containing mushroom polysaccharide and preparation method thereof
07/07/2010CN101766650A Washing liquor for operation and method for preparing same
07/07/2010CN101766645A Creatinine sorbent
07/07/2010CN101766641A Compound glycyrrhizin injection preparation
07/07/2010CN101766631A Prostaglandin composition for injection
07/07/2010CN101766615A Pantoprazole sodium combined drug
07/07/2010CN101766614A Omeprazole sodium combined medicament and preparation method thereof
07/07/2010CN101766591A Method for preparing water-soluble ethopabate and application thereof
1 ... 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 ... 1712